Digital twins began as static digital models used primarily for visualization and design. The review shows that they have ...

NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today reported completion of ...

Treating accessibility as a core product requirement, not a compliance checkbox, is a competitive advantage that most of your ...

Some requests by reviewers to cite their own publications are coercive and can unnecessarily delay indexation and publication.

NeuroSense (NRSN) reported completion of the safety analysis from its proof-of-concept Phase 2, randomized, double-blind, placebo-controlled ...

AI design contest turns the future Forester into everything from a jungle tank to a rolling dessert, with fans now voting on ...

Critical illness poses a significant global health challenge, disproportionately affecting low- and middle-income countries ...

The biggest source of teachers’ hesitation appears to be concerns about developmental appropriateness for young children.

Background Global warming poses a significant threat to human mental health, with disproportionate effects on vulnerable and ...

Objective To determine whether a full-scale randomised control trial (RCT) assessing the efficacy and cost-effectiveness of a ...

The approval of Emeprev will help veterinary professionals by providing an in-clinic antiemetic option.

You glance at a menu, thinking you're making your own decision about what to order. The pasta sounds good. Maybe the salmon?